Glucagon-like peptide-1 (GLP-1) receptor agonists and dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonists help manage blood sugar in type 2 diabetes. They may also support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results